Possible delayed diagnosis and treatment of metastatic differentiated thyroid cancer by adopting the 2015 ATA guidelines.

@article{Albano2018PossibleDD,
  title={Possible delayed diagnosis and treatment of metastatic differentiated thyroid cancer by adopting the 2015 ATA guidelines.},
  author={Domenico Albano and Francesco Bertagna and Mattia Bonacina and Rexhep Durmo and Elisabetta Cerudelli and Maria Gazzilli and Maria Beatrice Panarotto and Anna Maria Formenti and Gherardo Mazziotti and Andrea Giustina and Raffaele Giubbini},
  journal={European journal of endocrinology},
  year={2018},
  volume={179 3},
  pages={
          143-151
        }
}
OBJECTIVE According to the 2015 American Thyroid Association (ATA) guidelines, thyroid ablation by iodine-131 (I-131) therapy is absolutely recommended only in patients with high-risk differentiated thyroid cancer (DTC). Often distant metastases are not recognized early and they can stay silent for long time. The aim of our study was to retrospectively analyze the prevalence of metastatic disease before and after I-131 and to evaluate the influence of the new ATA guidelines in the management of… CONTINUE READING
3
Twitter Mentions

References

Publications referenced by this paper.
SHOWING 1-10 OF 40 REFERENCES

The utility of I-123 pretherapy scan in I-131 radioiodine therapy for thyroid cancer.

  • Thyroid : official journal of the American Thyroid Association
  • 2012
VIEW 6 EXCERPTS
HIGHLY INFLUENTIAL

Comparison of outcomes after (123)I versus (131)I pre-ablation imaging before radioiodine ablation in differentiated thyroid carcinoma.

  • Journal of nuclear medicine : official publication, Society of Nuclear Medicine
  • 2007
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL

Cancer statistics, 2018.

  • CA: a cancer journal for clinicians
  • 2018
VIEW 1 EXCERPT